Andere Sprachen Inari Medical, Inc.

Aktien

A2P41U

US45332Y1091

NARI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 25.04.2024			% 5 Tage	% 1. Jan.
38.07 ^USD	-0.29%		-1.48%	-41.36%

02.04.	Inari Medical, Inc. ernennt Tim Benner zum Senior Vice President für den Vertrieb in den USA	CI
26.03.	Sektor Update: Finanzwerte legen am späten Nachmittag zu	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Inari Medical to Announce First Quarter 2024 Financial Results	17.04.
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report	11.04.
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives	02.04.
Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales	02.04.
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care	01.04.
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600	01.04.
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400 Health Care	01.04.
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400	01.04.
Sector Update: Financial Stocks Gain Late Afternoon	26.03.
Sector Update: Financial Stocks Rise Tuesday Afternoon	26.03.
AppFolio to Join S&P MidCap 400, Inari Medical to Join S&P SmallCap 600; AppFolio Shares Rise	26.03.
Sector Update: Tech Stocks Mixed Premarket Tuesday	26.03.
Sector Update: Tech	26.03.
AppFolio to Join S&P MidCap 400, Inari Medical to Join S&P SmallCap 600	26.03.
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inari Medical, Inc.- NARI	19.03.
Inari Medical Insider Sold Shares Worth $251,461, According to a Recent SEC Filing	14.03.
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry	12.03.
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry	12.03.
Inari Medical Investigation: Kessler Topaz Meltzer & Check, LLP Investigates The Inari Medical, Inc. (NASDAQ: NARI) for Potential Securities Violations	12.03.
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	11.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Inari Medical, Inc.

Aktien

A2P41U

US45332Y1091

NARI

Andere Sprachen

Filter